(Total Views: 91)
Posted On: 11/27/2024 6:37:03 PM
Post# of 45003

$SHPH Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
https://www.globenewswire.com/news-release/20...tient.html
https://www.globenewswire.com/news-release/20...tient.html

